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If the large pool is positive, the 
three sub­pools are reanalysed, 
and then the individual samples 
of the positive sub­pool. In our 
analyses during March 13–21, 2020, 
testing of 1191 samples required 
only 267 tests to detect 23 positive 
individuals (prevalence 1·93%). The 
rate of positive tests was 4·24% in our 
institution during this period.
These data suggest that pooling of 
up to 30 samples per pool can increase 
test capacity with existing equipment 
and test kits and detects positive 
samples with sufficient diagnostic 
accuracy. We must mention that 
borderline positive single samples 
might escape detection in large 
pools. We see these samples typically 
in convalescent patients 14–21 days 
after symptomatic infection. The 
pool size can accommodate 
different infection scenarios and 
be optimised according to infra­
structure constraints.
Figure: Ct values of single versus pooled samples
Absolute Ct values of positive pools (13 of 164 tested pools) in relation to pool size and corresponding 
Ct values of individual positive samples for the E­gene assay (A) and the S­gene assay (B). Absolute Ct values 
were below 30 for all pool sizes. Three positive individual samples with Ct values greater than 30 were spiked 
into negative pools of 30 samples and tested with E­gene (C) and S­gene (D) assays. We hypothesise that the 
lower Ct values of pools than of single samples were because of the carrier effect of the higher RNA content 
in pools. Connecting lines show positive single samples and their corresponding pools. Ct=cycle threshold. 
E­gene=envelope protein gene. S­gene=spike protein gene.
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Challenges and issues of 
SARS-CoV-2 pool testing
We read with interest Stefan Lohse 
and colleagues’ Correspondence 
about sample pooling for testing for 
severe acute respiratory syndrome 
coronavirus 2 (SARS­CoV­2) in 
asymptomatic people.1 Some of 
the findings Lohse and colleagues 
report do not seem to be consistent 
with other research results2,3 nor our 
experiences.
In panels C and D of the figure in 
Lohse and colleagues’ letter,1 which 
show the three pooled samples, there 
is one positive sample in 30 negative 
samples in each pool, and the pooled 
samples show lower Ct values than do 
single samples, which suggests the RNA 
concentration increased after pooling. 
Considering that concentrations of 
RNA had been reduced to 1/31 in the 
pooled specimens, the Ct values were 
expected to increase by five compared 
with single samples. However, in 
figures C and D, the actual Ct values 
of the pooled specimens were 
approximately six values lower than 
expected, corresponding to a 60­fold 
increase in RNA concentration.4 By 
contrast, we found that when testing 
pooling of 50 nasopharyngeal and 
oropharyngeal samples, Ct values 
(RdRp gene) increased with pool size 
(appendix).
Lohse and colleagues attribute the 
decreased Ct values to the carrier effect 
from a higher RNA content in the pool; 
however, we did not observe a similar 
phenomenon in 600 tests. Lohse and 
colleagues did not describe clearly 
whether the experiment was done 
with media pooling or swab pooling 
in a single tube. To our knowledge, 
the NucliSens easyMAG instrument 
does not use carrier RNA or DNA for 
extraction, and there was no evidence 
to support the carrier phenomenon in 
the Correspondence.
During our experiments, we observed 
a few instances wherein the Ct value 
decreased despite an increased pool 
size. However, the changes in Ct value 
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In our laboratory, as suggested 
by the Indian Council of Medical 
Research,3 we are testing four samples 
in a pool. Some pools have been 
inadequate (RNAse P not detected), 
which was resolved when individual 
testing was attempted. Absence of 
RNAse P in a pool might be due to an 
inhibitory effect of concentrated RNA 
samples on reverse transcription.4 
Large­scale validation of SARS­CoV­2 
sample pooling strategies addressing 
these technical issues is needed to 
reach a consensus strategy.
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and colleagues evaluated a range of 
pool sizes (four to 30 samples per 
pool) in asymptomatic people. The 
additional time to deconvolute the 
larger pools yielding a positive result 
into sub­pools precludes the use of 
this strategy in patients with severe 
acute respiratory illness and high­
risk contacts. Moreover, most of the 
studies on pooled sample testing have 
not discussed the crucial technical 
points. Here, we raise certain technical 
issues pertaining to SARS­CoV­2 pool 
testing.
First, sample collection for 
SARS­CoV­2 testing in field settings 
is done without supervision and 
dependent on the skill of the people 
doing the test. The crucial pre­
analytical variable in SARS­CoV­2 
testing is the amount of host RNA 
(detected by RNAse P). Before we 
adopted pool testing in our laboratory, 
approximately 3% of individual 
samples tested showed no RNAse P 
amplification, indicating inadequate 
sample collection, which was resolved 
on repeat sample collection. Such 
a sample would have been missed 
in pooled testing and might have 
been reported as negative despite an 
inadequate amount of clinical material.
Second, Lohse and colleagues 
attributed the lower Ct values of pools 
than of single samples to the carrier 
effect of the higher RNA content 
in pools. If the same hypothesis 
is applicable to the adequacy of a 
sample, then inadequate samples in 
a large pool will be falsely reported as 
negative.
Third, different RNA extraction 
kits recommend different volumes 
of sample, ranging from 140 µL to 
200 µL. It is not clear how Lohse and 
colleagues addressed the issues of 
total amount of pooled sample and 
the minimum amount of each sample 
to be added in pool sizes ranging from 
four to 30 samples. In a large pool of 
up to 30 samples, if we take 5–10 µL 
of each sample, there is every chance 
of missing borderline­positive single 
samples.2
and pooling size were small and so 
could probably be explained by random 
variation in the PCR or pooling process 
with small volumes. By contrast, the 
difference between the expected 
and observed Ct values in Loshe and 
colleagues’ study was large and so could 
not be attributed to random variation. 
A decrease in Ct value after pooling with 
negative specimens might cause a false­
positive result and would be regarded as 
contamination in a clinical setting.
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Stefan Lohse and colleagues1 described 
a sample pooling strategy for testing 
for severe acute respiratory syndrome 
coronavirus 2 (SARS­CoV­2) via 
RT­PCR to meet the unprecedented 
demand for laboratory testing. Lohse 
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We read with interest the Corres­
pondence by Stefan Lohse and 
colleagues,1 who evaluated the 
practicability of pool testing for 
severe acute respiratory syndrome 
coronavirus 2 (SARS­CoV­2). Pooling 
of samples yields considerable 
savings of test kits when the 
prevalence of infection is low because 
pools with all­negative samples can 
be discarded with a single test. Lohse 
and colleagues’ findings suggest that 
pooling up to 30 samples is technically 
feasible with currently used and 
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